Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent
1989-04-13
1991-07-02
Moezie, F. T.
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
424 857, A61K 3766
Patent
active
050284223
ABSTRACT:
This invention relates to a method of treating basal cell carcinoma with purified human recombinant DNA interferon alpha-2, preferably purified human recombinant DNA interferon alpha-2b by administering intralesionally (by injection) to a patient in need of such treatment, a sufficient amount of the purified human recombinant DNA alpha interferon, preferably recombinant DNA interferon alpha-2b, to be effective as an antitumor agent.
REFERENCES:
patent: 4289690 (1981-09-01), Pestka et al.
patent: 4503035 (1985-03-01), Pestka et al.
patent: 4530901 (1985-07-01), Weissman
patent: 4959210 (1990-09-01), Smiles et al.
Ikeda, Japan Journal of Cancer Chemotherapy, 12(4), 936-942 (1985).
Ikic, D., Interferon and Cancer (Editor, Sikora K.), 169-181, Plenum Press (1983).
Barenbein et al., Vestn. Dermatology, Venerol No. (4): 31-33 (1985).
Ikic et al., The Lancet, May 9, 1981, pp. 1025-1027.
Langer et al., J. Invest. Dermatology 63, 1285-1365 (1984).
Staehelin et al., Methods in Enzynology 78 Part A. 505,511 (1981) Academic Press, N.J.
Rubenstein, Biochem. Biophys. Acta. 695, 5-16 (1982).
Nagata et al., Nature 284, 316-320 (1980).
Rook et al., Textbook of Dermatology, Fourth Edition, vol. 3 (Blackwell Scientific Publications), p. 2431-2437.
The Merck Index, Eleventh Edition (Merk & Co., Inc., Rahway, N.J.), p. 4895 (1989).
Genetic Tech. News, 6, No. 10, 1986, p. 5 (Greenway et al.).
J. Am. Acad. Dermat., 15 No. 3, Sept. 1986, pp. 437-443 (Greenway et al.)
Smiles et al. The Biology of the Interferon System, pp. 493-501.
Morita et al., Acta Dermatol-Kyoto 81(2), pp. 241-246, 1986.
Eron et al., The New England Journal of Medicine, vol. 315, No. 17, pp. 1059-1064 (1986).
Peets Edwin A.
Smiles Kenneth A.
Tanner Daniel J.
Dicker Eric S.
Jeanette Henry C.
Moezie F. T.
Rosen Gerald S.
Rozycki Andrew G.
LandOfFree
Treatment of basal cell carcinoma intralesionally with recombina does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of basal cell carcinoma intralesionally with recombina, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of basal cell carcinoma intralesionally with recombina will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1245547